Letter to the editor

Toxicologic Pathology

Volumn 35, Issue 2, 2007, Pages 325-

  Berridge, Brian R ^a   Chatman, Linda A ^b   Odin, Marielle ^c   Schultze, Albert Eric ^d   Losco, Patricia E ^e   Meehan, James T ^f   Peters, Terry ^g   Vonderfecht, Steven L ^h  

^a GLAXOSMITHKLINE   (United Kingdom)

^b PFIZER GLOBAL RESEARCH AND DEVELOPMENT   (United States)

^c MERCK RESEARCH LABORATORIES   (United States)

^d ELI LILLY AND COMPANY   (United States)

^e Schering Plough Research Institute   (Germany)

^f PFIZER INC   (United States)

^g CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^h AMGEN INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; PHOSPHOLIPID;

CELL DAMAGE; CLINICAL PRACTICE; COMPUTER MODEL; DATA BASE; DRUG INDUSTRY; FOOD AND DRUG ADMINISTRATION; GENE EXPRESSION; IN VITRO STUDY; IN VIVO STUDY; LETTER; LIPIDOSIS; LYSOSOME STORAGE DISEASE; MARKER GENE; MEDICAL SOCIETY; PRIORITY JOURNAL; RISK ASSESSMENT; TOXICITY; TOXICOGENETICS; ANIMAL; CHEMICALLY INDUCED DISORDER; DRUG TOXICITY; HUMAN; METABOLISM; METHODOLOGY; TOXICITY TESTING; UNITED STATES;

ANIMALS; BIOLOGICAL MARKERS; DRUG TOXICITY; HUMANS; LIPIDOSES; PHOSPHOLIPIDS; RISK ASSESSMENT; TOXICITY TESTS; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 33847771445     PISSN: 01926233     EISSN: 15331601     Source Type: Journal    
DOI: 10.1080/01926230701196414     Document Type: Letter

References (0)